Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.
Kothari R, Patil V, Madala RK, Singh R, Talreja VT, Pathak A, Shrirangwar S, Mandal TK, Das S, Turkar S, Pande N, Chandrasekharan A, Singh G, Gupta TC, Poladia B, Avaronnan M, Wilson L, Raut N, Jadhav M, Alone M, Kolkur M, Bhagyavant P, Pathak S, Peelay Z, Modi G, Khatwani I, Bhatt P, Kumar G, Jha B, Singh U, Madankar K, Sen N, Sonwani V, Muley S, Thavarool SB, Bhosale B, Katna R, Rajamanickam D, Rajamanickam S, Shenoy Vp PK, Karpe A, Banavali SD, Noronha V, Prabhash K.
Kothari R, et al. Among authors: poladia b.
Cancer Lett. 2025 Jul 1;621:217702. doi: 10.1016/j.canlet.2025.217702. Epub 2025 Apr 8.
Cancer Lett. 2025.
PMID: 40209850
Clinical Trial.